The gene ratios c-MYC: Cyclin-dependent kinase (CDK)N2A and CCND1: CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck

Clinical Cancer Research

Volumn 9, Issue 5, 2003, Pages 1750-1755

  Akervall, Jan ^a,e   Bockmühl, Ulrike ^b   Petersen, I ^d   Yang, Kun ^a,c   Carey, Thomas E ^a   Kurnit, David M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Fulda University Hospital   (Germany)

^c LUND UNIVERSITY   (Sweden)

^d HUMBOLDT UNIVERSITY   (Germany)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; DNA; PROTEIN P16;

ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUTH CARCINOMA; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; OROPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; CYCLIN D1; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE DOSAGE; GENES, MYC; GENES, P16; HEAD AND NECK NEOPLASMS; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 0038666344     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Akervall, J. (ed.). Prognostic Factors in Squamous Cell Carcinoma of the Head and Neck, Medical Thesis. Department of Otolaryngology, Head and Neck Surgery. Lund, Sweden: Lund University, 1998.
2. Imoto, M., Doki, Y., Jiang, W., Han, E., and Weinstein, I. Effects of cyclin D1 overexpression on G1 progression related events. Exp. Cell Res., 236: 173-180, 1997.
3. La Thangue, N. DRTF1/E2F: an expanding family of hetero dimeric transcription factors implicated in cell cycle control. Trends Biochem. Sci., 19: 108-114, 1994.
4. Jiang, W., Kahn, S., Zhang, Y., Cacae, A., Infante, A., Doi, S., Santella, R. M., and Weinstein, I. B. Overexpression of cyclin D1 in rat fibroblats causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene, 8: 3447-3457, 1993.
5. Hinds, P., Dowdy, S., Eaton, E., Arnold, A., and Weinberg, R. Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. USA, 91: 709-713, 1994.
6. Akervall, J., Jin, Y., Wennerberg, J., Zatterstrom, U., Kjellén, E., Mertens, F., Willén, R., Mandahl, N., and Mitelman, F. Chromosomal abnormalities involving I1q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer (Phila.), 76: 853-859, 1995.
7. Bockmuhl, U., Schluns, K., Kuchler, I., Petersen, S., and Petersen, I. Genetic imbalances with impact on survival in Head and Neck cancer patients. Am. J. Pathol., 157: 369-375, 2000.
8. Williams, M., Gaffey, M., Weiss, L., Wilczynski, S., Schuuring, E., and Levine, P. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg., 119: 1238-1243, 1993.
9. Meredith, S., Levine, P., Burns, J., Gaffey, M., Boyd, J., Ericksson, N., and Williams, M. E. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis. Arch. Otolaryngol. Head Neck Surg., 121: 790-794, 1995.
10. Kyomoto, R., Kumazawa, H., Toda, Y., Sakaida, N., Okamura, A., Iwanaga, M., Shintaku, M., Yamashita, T., Hiai, H., and Fukumoto, M. Cyclin D1 gene amplification is a more potent prognostic factor than its protein overexpression in human head and neck squamous cell carcinoma. Int. J. Cancer, 74: 576-581, 1997.
11. Michalides, R., van Veelen, N., Hart, A., Loftus, B., Wientjens, E., and Balm, A. Overexpression of cyclin D1 correlates with recurrence in a group of 47 operable squamous cell carcinomas of the head and neck. Cancer Res., 55: 975-978, 1995.
12. Masuda, M., Hirakawa, N., Nakashima, T., Kuratomi, Y., and Komiyama, S. Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Cancer (Phila.), 78: 390-395, 1996.
13. Michalides, R., van Veelen, N., Kristel, P., Hart, A., Loftus, B., Hilgers, F., and Balm, A. Overexpression of cyclin D1 indicates poor prognosis in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg., 123: 497-502, 1997.
14. Akervall, J., Brun, E., Michalides, R., Dictor, M., Balm, A., and Wennerberg, J. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 over expression. Cancer, 79; 380-389, 1997.
15. Serrano, M., Hannon, G., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704-717, 1993.
16. Liggett, W., Sewell, D., Rocco, J., Ahrendt, S., Koch, W., and Sidransky, D. p16 and p16 β are potent growth suppressors of head and neck squamous carcinoma cells in vitro. Cancer Res., 56: 4119-4123, 1996.
17. Shin, D. M., Lee, J. S., Lippman, S. M., Lee, J. J., Tu, Z. N., Choi, G., Heyne, K., Shin, H. J., Ro, J. Y., Goepfert, H., and Hong, W. K., and Hittelman, W. N. p53 expression: predicting recurrence and secondary primary tumors in head and neck squamous cell carcinoma. J. Natl. Cancer Inst. (Bethesda), 88: 519-529, 1996.
18. Liggett, W., and Sidransky, D. Role of the p16 tumor suppressor gene in cancer. J Clin. Oncol., 16: 1197-1206, 1998.
19. Jen, J., Harper, W., Bigner, S., Bigner, D., Papadopoulos, N., Markowitz, S., Willson, J. K. V., Kinzler, K. W., and Vogelstein, B. Deletion of p16 and p15 genes in brain tumors. Cancer Res., 54: 6353-6358, 1994.
20. Reed, A., Califano, J., Cairns, P., Westra, W., Jones, R., Koch, W., Ahrendt, S., Eby, Y., Sewell, D., Nawroz, H., Bartek, J., and Sidransky, D. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res., 56: 3630-3633, 1996.
21. Cairns, P., Polascik, T., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., and Westra, W. Frequency of homozygous deletion at p16/CDKN2 in primary human tumors. Nat. Genet., 11: 210-212, 1995.
22. Akanuma, D., Uzawa, N., Yoshida, M., Negishi, A., Amagasa, T., and Ikeuchi, T. Inactivation patterns of p16 (INK4A) gene in oral squamous cell carcinoma cell lines. Oral Oncol., 35: 476-483, 1999.
23. Dang, C. V. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol., 19: 1-11, 1999.
24. Obaya, A. J., Mateyak, M. K., and Sedivy, J. M. Mysterious liaisons: the relationship between c-Myc and the cell cycle. Oncogene, 18: 2934-2941, 1999.
25. Little, C. D., Nau, M. M., Carney, D. N., Gazdar, A. F., and Minna, J. D. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature (Lond.), 306: 194-196, 1983.
26. Mariani-Costantini, R., Escot, C., Theillet, C., Gentile, A., Merlo, G., Liderau, R., and Callahan, R. In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast. Cancer Res., 48: 199-205, 1988.
27. Munzel, P. D., Marx, H., Kochel, A., Schauer, A., and Bock, K. W. Genomic alterations of the c-myc proto-oncogene in relation to the overexpression of c-erbB2 and Ki-67 in human breast and cervix carcinomas. J. Cancer Res. Clin. Oncol., 117: 603-607, 1991.
28. de la Guardia, C., Casiano, C. A., Trinidad-Pinedo, J., and Baez, A. Cenp-F gene amplification and overexpression in head and neck squamous cell carcinomas. Head Neck, 23: 104-112, 2001.
29. Lee, L., Connell, C., and Bloch, W. Allelic discrimination by nick translation PCR with fluorogenic probes. Nucleic Acids Res., 21: 3761-3766, 1993.